Dual-use Catheter for Continuous Analyte Measurement and Drug Delivery

• US 20140296823A1
• Filed: 06/13/2014
• Published: 10/02/2014
• Est. Priority Date: 12/14/2011
• Status: Abandoned Application

• Current Assignee: Oregon State University (Oregon University System), Pacific Diabetes Technologies, Inc.
• Original Assignee: Oregon State University (Oregon University System), Pacific Diabetes Technologies, Inc.
• Inventors: Ward, William Kenneth, Jacobs, Peter G., Cargill, Robert S., Castle, Jessica R., Herman, Gregory, Conely, John
• Application Number:
  US14/304,166
• Publication Number:
  US 20140296823A1
• Time in Patent Office: Days
• US Class Current: 604/504
• CPC Class Codes: A61B 5/14532 for measuring glucose, e.g. by tissue impedance measurement
• CPC Class Codes: A61B 5/1473 invasive, e.g. introduced into the body by a catheter A61B5/1482 takes precedence
• CPC Class Codes: A61B 5/4839 combined with drug delivery
• CPC Class Codes: A61M 2025/0057 Catheters delivering medicament other than through a conventional lumen, e.g. porous walls or hydrogel coatings
• CPC Class Codes: A61M 2230/005 Parameter used as control input for the apparatus
• CPC Class Codes: A61M 2230/201 Glucose concentration
• CPC Class Codes: A61M 25/0009 Making of catheters or other medical or surgical tubes
• CPC Class Codes: A61M 25/0017 specially adapted for long-term hygiene care, e.g. urethral or indwelling catheters to prevent infections
• CPC Class Codes: A61M 25/0043 characterised by structural features
• CPC Class Codes: Y10T 29/49826 Assembling or joining

Abstract

A sensing assembly (10), including a body (12) and one or more first indicating electrodes disposed on the body (26). The first indicating electrodes include an electrochemically active layer (32) and a layer (38) of an active functioning enzyme of a first enzyme type on top of the electrochemically active layer. Also, one or more second indicating electrodes (24) are disposed on the body and include an electrochemically active layer (32) and a layer (36) of an inactivated enzyme of the first enzyme type on top of the electrochemically active layer. A reference electrode (22) is also disposed on the body. Finally, an electrical and data processing system (18) is adapted to bias the electrodes and measure electrical signals from the electrodes, and uses said signals to determine an analyte concentration and communicates the analyte concentration to a location apart from the first and second indicating electrodes.

Claims

1. A catheter designed to be indwelled in a subcutaneous, dermal or intravascular location to deliver one or more drugs, said catheter being filled with porous material.

2. The catheter of claim 1, wherein said porous material is foam.

3. The catheter of claim 1, wherein said porous material is sponge material.

4. The catheter of claim 3, wherein said sponge material is selected from a group consisting of poly vinyl alcohol, poly-l-lactic acid or expanded polytetrafluoroethylene.

5. The catheter of claim 1, wherein said porous material has a porous material density is at least 35%.

6. The catheter of claim 1, wherein said porous material has a porous material density is at least 65%.

7. A method of sensing an analyte and delivering a drug, comprising:

a. providing a sensing macrocatheter assembly, including;

i. a macrocatheter tube having an exterior surface and a proximal end;

ii. a first indicating electrode disposed on said exterior surface and including an electrochemically active layer and a layer of an active functioning enzyme of a first enzyme type on top of said electrochemically active layer;

iii. a reference electrode disposed on said exterior surface;

iv. conductive traces disposed on said exterior surface, leading from said electrodes to a location near said proximal end; and

v. an electrical and data processing system, electrically connected to said conductive traces and adapted to bias said electrodes and measure electrical signals from said electrodes, and using said signals to determine concentration of an analyte concentration and communicating said analyte concentration to a location apart from said first and second indicating electrodes;

b. indwelling said sensing macrocatheter tube in a human patient'"'"'s subcutaneous, dermal or intravascular location;

c. using said indicating electrodes to sense concentration of one or more analytes, thereby forming sensed concentrations of one or more analytes; and

d. delivering one or more drugs through said macrocatheter tube in quantities responsive to said sensed concentrations of one or more analytes, but being corrected for effects of previously delivered drugs on analyte measurements.

8. The method of claim 7, in which said sensing microcatheter assembly includes a second indicating electrode, disposed on said exterior surface and including an electrochemically active layer and a layer of an inactivated enzyme of said first enzyme type on top of said electrochemically active layer.

9. The method of claim 7, in which said analyte is glucose.

10. The method of claim 7, in which said enzyme is selected from the group consisting of glucose oxidase and glucose dehydrogenase.

11. The method of claim 7, in which the delivered drug is taken from a group consisting of insulin, glucagon and pramlintide or a combination of two or more of said drugs.

12. The method of claim 7, wherein said macrocatheter tube is fabricated from a flexible material.

13. The method of claim 12, wherein said flexible material is polyimide.

14. A method of manufacturing a catheter having a sensing assembly on its exterior surface, comprising:

a. providing a catheter tube;

b. providing a flexible substrate;

c. producing a sensing assembly on a first side said flexible substrate; and

d. wrapping said flexible substrate about said catheter tube so that said first side of said flexible substrate faces out.

15. The method of claim 14, wherein said catheter tube is supported by a cylindrical support placed inside said catheter tube during said wrapping.